Compact-ultrasound technology developer SonoSite has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its NanoMaxx point-of-care ultrasound system.
Targeted at both the hospital and office markets, the 6-lb NanoMaxx system features one-button optimization technology, a touchscreen user interface, and a five-year warranty, according to the Bothell, WA-based vendor.
It includes five transducers to support examinations and procedures such as thoracic assessment for pathology, vascular access, and needle aspirations and injections, as well as abdominal, cardiac, nerve, ob/gyn, musculoskeletal, small parts, and vascular scanning, SonoSite said.
U.S. shipments of NanoMaxx are now under way, and international deliveries began in June, the company said.
Related Reading
SonoSite adds vascular technology, September 16, 2009
SonoSite hires new executive, September 11, 2009
SonoSite completes CardioDynamics acquisition, August 17, 2009
CardioDynamics OKs SonoSite deal, August 12, 2009
SonoSite revenue, income dip in Q2, July 28, 2009
Copyright © 2009 AuntMinnie.com
